Skip to content

Products

We’ve been providing innovative medicines to the UK since the 1920s; this is what our portfolio looks like today.

© 2024 NAPP PHARMACEUTICALS LIMITED. DOP February 2024 UK-CORP-2200003 v7.1

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”